Matches in Nanopublications for { ?s ?p "with a significant reduction in mortality of patients with ARDS due to COVID-19 , most probably via non-specific anti-inflammatory effects" ?g. }
Showing items 1 to 30 of
30
with 100 items per page.
- OBJECT label "with a significant reduction in mortality of patients with ARDS due to COVID-19 , most probably via non-specific anti-inflammatory effects" provenance.
- OBJECT label "with a significant reduction in mortality of patients with ARDS due to COVID-19 , most probably via non-specific anti-inflammatory effects" provenance.
- OBJECT label "with a significant reduction in mortality of patients with ARDS due to COVID-19 , most probably via non-specific anti-inflammatory effects" provenance.
- OBJECT label "with a significant reduction in mortality of patients with ARDS due to COVID-19 , most probably via non-specific anti-inflammatory effects" provenance.
- OBJECT label "with a significant reduction in mortality of patients with ARDS due to COVID-19 , most probably via non-specific anti-inflammatory effects" provenance.
- OBJECT label "with a significant reduction in mortality of patients with ARDS due to COVID-19 , most probably via non-specific anti-inflammatory effects" provenance.
- OBJECT label "with a significant reduction in mortality of patients with ARDS due to COVID-19 , most probably via non-specific anti-inflammatory effects" provenance.
- OBJECT label "with a significant reduction in mortality of patients with ARDS due to COVID-19 , most probably via non-specific anti-inflammatory effects" provenance.
- OBJECT label "with a significant reduction in mortality of patients with ARDS due to COVID-19 , most probably via non-specific anti-inflammatory effects" provenance.
- OBJECT label "with a significant reduction in mortality of patients with ARDS due to COVID-19 , most probably via non-specific anti-inflammatory effects" provenance.
- OBJECT label "with a significant reduction in mortality of patients with ARDS due to COVID-19 , most probably via non-specific anti-inflammatory effects" provenance.
- OBJECT label "with a significant reduction in mortality of patients with ARDS due to COVID-19 , most probably via non-specific anti-inflammatory effects" provenance.
- OBJECT label "with a significant reduction in mortality of patients with ARDS due to COVID-19 , most probably via non-specific anti-inflammatory effects" provenance.
- OBJECT label "with a significant reduction in mortality of patients with ARDS due to COVID-19 , most probably via non-specific anti-inflammatory effects" provenance.
- OBJECT label "with a significant reduction in mortality of patients with ARDS due to COVID-19 , most probably via non-specific anti-inflammatory effects" provenance.
- OBJECT label "with a significant reduction in mortality of patients with ARDS due to COVID-19 , most probably via non-specific anti-inflammatory effects" provenance.
- OBJECT label "with a significant reduction in mortality of patients with ARDS due to COVID-19 , most probably via non-specific anti-inflammatory effects" provenance.
- OBJECT label "with a significant reduction in mortality of patients with ARDS due to COVID-19 , most probably via non-specific anti-inflammatory effects" provenance.
- OBJECT label "with a significant reduction in mortality of patients with ARDS due to COVID-19 , most probably via non-specific anti-inflammatory effects" provenance.
- OBJECT label "with a significant reduction in mortality of patients with ARDS due to COVID-19 , most probably via non-specific anti-inflammatory effects" provenance.
- OBJECT label "with a significant reduction in mortality of patients with ARDS due to COVID-19 , most probably via non-specific anti-inflammatory effects" provenance.
- OBJECT label "with a significant reduction in mortality of patients with ARDS due to COVID-19 , most probably via non-specific anti-inflammatory effects" provenance.
- OBJECT label "with a significant reduction in mortality of patients with ARDS due to COVID-19 , most probably via non-specific anti-inflammatory effects" provenance.
- OBJECT label "with a significant reduction in mortality of patients with ARDS due to COVID-19 , most probably via non-specific anti-inflammatory effects" provenance.
- OBJECT label "with a significant reduction in mortality of patients with ARDS due to COVID-19 , most probably via non-specific anti-inflammatory effects" provenance.
- OBJECT label "with a significant reduction in mortality of patients with ARDS due to COVID-19 , most probably via non-specific anti-inflammatory effects" provenance.
- OBJECT label "with a significant reduction in mortality of patients with ARDS due to COVID-19 , most probably via non-specific anti-inflammatory effects" provenance.
- OBJECT label "with a significant reduction in mortality of patients with ARDS due to COVID-19 , most probably via non-specific anti-inflammatory effects" provenance.
- OBJECT label "with a significant reduction in mortality of patients with ARDS due to COVID-19 , most probably via non-specific anti-inflammatory effects" provenance.
- OBJECT label "with a significant reduction in mortality of patients with ARDS due to COVID-19 , most probably via non-specific anti-inflammatory effects" provenance.